MARKET

MBCOF

MBCOF

Marvel Biosciences Corp
OTCMQB
0.138
-0.001
-0.58%
Closed 12:04 06/09 EDT
OPEN
0.138
PREV CLOSE
0.138
HIGH
0.138
LOW
0.138
VOLUME
5.00K
TURNOVER
688
52 WEEK HIGH
0.241
52 WEEK LOW
0.070
MARKET CAP
8.67M
P/E (TTM)
-4.7612
1D
5D
1M
3M
1Y
5Y
1D
Marvel Biosciences awards 50,001 deferred share units to independent directors
PUBT · 05/20 11:11
Marvel Biosciences Announces Grant of Deferred Share Units
Newsfile · 05/20 11:00
Marvel Biosciences to present at Neuroscience Innovation Partnering and Licensing Summit
PUBT · 04/23 11:31
Marvel Biosciences closes $500,000 convertible debenture offering
PUBT · 04/17 20:47
Marvel Biosciences Announces Closing of Convertible Debenture Offering
Newsfile · 04/17 20:30
Marvel Biosciences identifies two pediatric liquid MB-204 formulations with up to 91% bioavailability
PUBT · 04/16 11:04
Marvel Biosciences lowers conversion price for proposed debenture offering
Seeking Alpha · 04/13 21:38
Marvel Biosciences cuts debenture conversion price to $0.17 per share
PUBT · 04/13 21:31
More
About MBCOF
Marvel Biosciences Corp. is a Canada-based pre-clinical-stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical derivatives of the original approved drug for the new disease indication. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The Company's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The Company is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.

Webull offers Marvel Biosciences Corp stock information, including OTCMQB: MBCOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBCOF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBCOF stock methods without spending real money on the virtual paper trading platform.